Trial Profile
A Randomised, Placebo-controlled Trial of Oral Nitazoxanide for the Empiric Treatment of Acute Gastroenteritis Among Australian Indigenous Children
Status:
Discontinued
Phase of Trial:
Phase II/III
Latest Information Update: 09 Feb 2024
Price :
$35
*
At a glance
- Drugs Nitazoxanide (Primary)
- Indications Gastroenteritis
- Focus Therapeutic Use
- Acronyms NICEGUT
- 06 Feb 2024 Status changed from recruiting to discontinued.
- 06 Aug 2020 Planned End Date changed from 1 Dec 2019 to 31 Dec 2021.
- 06 Aug 2020 Planned primary completion date changed from 1 Dec 2019 to 31 Dec 2021.